{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:03:26Z","timestamp":1791291806080,"version":"4.1.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,11,15]]},"DOI":"10.1097\/tp.0b013e318187bab0","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T08:24:52Z","timestamp":1226305492000},"page":"1187-1195","source":"Crossref","is-referenced-by-count":53,"title":["Comparison of Sirolimus Plus Tacrolimus Versus Sirolimus Plus Cyclosporine in High-Risk Renal Allograft Recipients: Results From an Open-Label, Randomized Trial"],"prefix":"10.1097","volume":"86","author":[{"given":"A Osama","family":"Gaber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry D.","family":"Kahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Van Buren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth L.","family":"Schulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Scarola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Neylan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210129","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/ki.1995.452","article-title":"Inferior outcome of two-haplotype matched renal transplants in blacks: Role of early rejection.","volume":"48","author":"Ojo","year":"1995","journal-title":"Kidney Int"},{"key":"R2-6-20210129","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/ki.1996.460","article-title":"The humoral immune response towards HLA class II determinants in renal transplantation.","volume":"50","author":"Feucht","year":"1996","journal-title":"Kidney Int"},{"key":"R3-6-20210129","first-page":"1","article-title":"Clinical transplantation.","author":"Cecka","year":"1998"},{"key":"R4-6-20210129","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1681\/ASN.2004040333","article-title":"Influence of race on kidney transplant outcomes within and outside the Department of Veterans Affairs.","volume":"16","author":"Chakkera","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R6-6-20210129","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0009-9120(98)00045-9","article-title":"Rapamune (RAPA, rapamycin, sirolimus): Mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression.","volume":"31","author":"Sehgal","year":"1998","journal-title":"Clin Biochem"},{"key":"R7-6-20210129","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/jcp.1041540103","article-title":"Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle.","volume":"154","author":"Terada","year":"1993","journal-title":"J Cell Physiol"},{"key":"R8-6-20210129","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0140-6736(00)02480-6","article-title":"Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: A randomised multicentre study.","volume":"356","author":"Kahan","year":"2000","journal-title":"Lancet"},{"key":"R9-6-20210129","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00007890-200101270-00019","article-title":"A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus\/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts.","volume":"71","author":"MacDonald","year":"2001","journal-title":"Transplantation"},{"key":"R10-6-20210129","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0140-6736(99)03882-9","article-title":"Sirolimus-tacrolimus combination immunosuppression.","volume":"355","author":"McAlister","year":"2000","journal-title":"Lancet"},{"key":"R11-6-20210129","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM200007273430401","article-title":"Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.","volume":"343","author":"Shapiro","year":"2000","journal-title":"N Engl J Med"},{"key":"R12-6-20210129","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/jlts.2001.23012","article-title":"Liver transplantation using sirolimus and minimal corticosteroids (3-day taper).","volume":"7","author":"Trotter","year":"2001","journal-title":"Liver Transpl"},{"key":"R13-6-20210129","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2307\/2528901","article-title":"Analysis of categorical data by linear models.","volume":"25","author":"Grizzle","year":"1969","journal-title":"Biometrics"},{"key":"R14-6-20210129","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1111\/j.1600-6143.2005.01057.x","article-title":"Kidney transplant in black recipients: Are African Europeans different from African Americans?","volume":"5","author":"Pallet","year":"2005","journal-title":"Am J Transplant"},{"key":"R15-6-20210129","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1016\/j.transproceed.2005.10.090","article-title":"Individualization of immunosuppressive therapy. I. Sirolimus improves outcomes in African-American renal transplant recipients.","volume":"37","author":"Podder","year":"2005","journal-title":"Transplant Proc"},{"key":"R16-6-20210129","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1399-0012.2004.00116.x","article-title":"Observations regarding the use of sirolimus and tacrolimus in high-risk cadaveric renal transplantation.","volume":"18","author":"Lo","year":"2004","journal-title":"Clin Transplant"},{"key":"R17-6-20210129","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1399-0012.2005.00331.x","article-title":"Concentration-controlled use of sirolimus associated with reduced exposure of cyclosporine in black recipients of primarily living renal allograft donors: 12-month results.","volume":"19","author":"Ferreira","year":"2005","journal-title":"Clin Transplant"},{"key":"R18-6-20210129","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1111\/j.1600-6143.2005.01019.x","article-title":"Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus.","volume":"5","author":"Meier-Kriesche","year":"2005","journal-title":"Am J Transplant"},{"key":"R19-6-20210129","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1600-6143.2005.01193.x","article-title":"Tacrolimus combined with two different dosages of sirolimus in kidney transplantation: Results of a multicenter study.","volume":"6","author":"Vitko","year":"2006","journal-title":"Am J Transplant"},{"key":"R20-6-20210129","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/01.TP.0000153506.07816.F0","article-title":"Induction therapy with basiliximab versus thymoglobulin in African-American kidney transplant recipients.","volume":"79","author":"Haririan","year":"2005","journal-title":"Transplantation"},{"key":"R21-6-20210129","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7326\/0003-4819-128-10-199805150-00004","article-title":"The effect of antilymphocyte induction therapy on renal allograft survival. A meta-analysis of individual patient-level data. Anti-Lymphocyte Antibody Induction Therapy Study Group.","volume":"128","author":"Szczech","year":"1998","journal-title":"Ann Intern Med"},{"key":"R22-6-20210129","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa060068","article-title":"Rabbit antithymocyte globulin versus basiliximab in renal transplantation.","volume":"355","author":"Brennan","year":"2006","journal-title":"N Engl J Med"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0b013e318187bab0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:16:11Z","timestamp":1620976571000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-200811150-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,15]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e318187bab0","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11,15]]}}}